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We  previously emphasized  (1,  2)  the  usefulness  of atopic allergy as a  model  for 
studying the genetics of human immune response. A particular advantage is that most 
allergies result from exposure to minute, immunogenically limiting doses of environ- 
mental antigens  (allergens), usually <1 ptg/yr (3).  Short ragweed pollen component 
Ra5 (5,000 tool wt) (4, 5) offers a particularly useful tool for studying specific immune 
response because of its relatively simple structure and low proportion in  the pollen 
(3).  In several studies  (2, 6-8), immunoglobulin E  (IgE)-mediated skin test response 
to  Ra5  was significantly associated with  HLA-B7 and  the  B7 cross-reacting group 
(Creg). x Further preliminary evidence suggested that the primary association might 
be with Dw2 (2). 
Analysis of the Ra5 preparations used in previous studies by crossed immunoelec- 
trophoresis  (CIE)  indicated  the  presence  of  very  low  (but  detectable)  levels  of 
impurities that might interfere with genetic analysis.  Hence, further purification  of 
Ra5  to -->99.9% purity was performed  for the  present  studies,  and  highly  sensitive 
assays for IgE and IgG antibodies (Ab) to Ra5 were developed. 
After studying responses to ultra-pure Ra5 in 447 Caucasians that were naturally 
exposed to ragweed pollen, we now find that Dw2 is almost a perfect marker for IgE 
and  IgG  responses  to  Ra5.  The  immune  response  association  with  HLA-B7  is 
secondary to Dw2 and presumably arises from the well-documented linkage disequi- 
librium  between the alleles coding for these two specificities.  Analysis of HLA-DR 
typing data in a  portion of the study subjects suggests a  weaker association between 
response to Ra5 with DR2 than with Dw2. 
* Supported by grant AI-13370 from the National Institutes of Health and contract BOB 223-79-1214 
from the Food and Drug Administration. This is publication 462 from the O'Neill Laboratories of the 
Good Samaritan Hospital. 
1  Abbreviations  used in thispaper:  AB, antibody; BSA, bovine  serum albumin; BBS, borate-buffered  saline, 
pH 8.3; CIE, crossed immunoelectrophoresis;  Creg, cross-reacting  group (of HLA antigens); DNV, double- 
normalized values; Dw2+(-),  positive (negative) for HLA specificity Dw2; HLA, human  leukocyte 
antigen; HSA, human serum albumin; Ra5+(-), positive (negative) response to RaS; RAST, radioal- 
lergosorbent test; RIA, radioimmunoassay. 
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Materials and  Methods 
Study Groups.  Two groups of unrelated subjects of Euro-Caucasian origin were studied• The 
first  consisted  of 86  individuals  (50  male,  36  female;  mean  age  38  +  10  yr),  who  were 
participating in various immunologic and clinical studies of ragweed allergy in the Division of 
Clinical Immunology (9-13).  2 Serum  samples were available on  85  of these 86  individuals. 
Where patients were to be scheduled for immunotherapy with ragweed antigens (14), sera were 
collected before therapy and stored at -70°C or -20°C.  (It should, however, be noted that 
27% of the patients had received immunotherapy with ragweed from their private physician 
sometime in the past, but not in the 2 yr before serum samples were drawn•) All subjects had 
been carefully selected because of their severe hay fever toward ragweed pollen, which was well 
documented by clinical history and symptom diaries. All patients were also strongly positive to 
short ragweed pollen extract by skin test, histamine release, and radioallergosorbent test (RAST) 
assays (10). 
A second group comprising 361 individuals (271 male, 90 female; mean age 39 +  10 yr) were 
employees of the Westinghouse Electric Corporation, Hunt  Valley, Baltimore County, MD. 
These subjects were part of a large genetic-epidemiologic  study of human immune responsive- 
ness  to allergens, described in  detail elsewhere (15).  This population was comprised of 119 
randomly selected subjects, together with a further 242 subjects selected on the basis of age and 
residence criteria and of reported allergy toward pollens and/or animals. 11% of 101 ragweed- 
positive subjects (see Skin Test Procedures) reported having received ragweed immunotherapy 
in the past, and 4% were currently receiving therapy. 
In the Westinghouse population, all study subjects were HLA typed. In the study of clinic 
patients, we focused on sampling all available Ra5-positive (Ra5+) subjects (from a group of 
about  300  people) along with appropriate Ra5-negative (Ra5-)  (although highly ragweed- 
sensitive) controls, matched by age, sex, and ongoing therapy with ragweed• 
Antigens.  Dialyzed extract of short  ragweed (Ambrosia elatior) pollen was prepared as de- 
scribed elsewhere (15). The preliminary evaluation of skin test response to Ra5 was performed 
using one or more of three different samples of Ra5 prepared by us or kindly supplied by Dr. 
Lawrence Goodfriend, McGill University, Montreal,  Canada•  Although  these  preparations 
were homogeneous according to conventional physicochemical and immunochemical analyses 
(4, 6-8,  16), more discriminating analysis by CIE against concentrated IgG immunoglobulins 
from rabbits hyperimmunized with crude ragweed extract revealed the presence of one or two 
minor impurities in all preparations (cf. analysis of preparation Ra5-1 in ref. 17). In view of the 
extremely high sensitivity of human allergic response to trace (but potentially highly allergenic) 
contaminants, further purification of Ra5 was deemed necessary. 
For the present study, we produced an ultra-pure Ra5 preparation of  lsoallergen Ra5  , 
for which the estimated purity was ~'99.9% (18). 3 In brief, short ragweed fraction C  (19), kindly 
supplied by Dr. Daniel Mullally, National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, Bethesda, MD, was further fractionated by uhrafiltration, using a series of 
Amicon hollow-fiber devices (Amicon Corp•, Scientific Sys. Div., Lexington, MA), followed by 
column  chromatography on  CM-Sephadex  (twice)  and  Biogel P10  (twice)•  Contaminating 
proteins were rigorously monitored and progressively eliminated at each stage of chromato- 
graphic  fractionation.  The  final  material  was  homogeneous  by  gel  filtration, agarose  gel 
electrophoresis at pH 8.6, sodium dodecyl sulfate-polyacrylamide  gel electrophoresis, and CIE, 
and gave a  single amino acid sequence for 20 N-terminal residues (18) corresponding to the 
published major Ra5 sequence (5). 
A comparison by CIE of the final Ra5A isolate vs. a crude 16-min extract of ragweed pollen 
demonstrated the ultra-purity of the Ra5A preparation (Fig. 1). Although we could detect ~20 
different cathodic antigens in the crude extract using a  potent anti-ragweed IgG pool raised 
primarily toward basic ragweed antigens, the Ra5A antigen gave only a single immunoprecip- 
2 Marsh,  D.  G., E.  Ehrlich-Kautzky,  and P~  S.  Norman.  1981. A kinetic study  of human  immune 
response toward injection of ragweed allergen and allergoid. Manuscript  in preparation. 
M. Roebber, D. G. Klapper, and D. G. Marsh. Two isoallergens of short ragweed component  Ra5. 
Manuscript  submitted for publication. ~
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irate. 4 The same result was obtained by Dr. Henning Lowenstein (personal communication)  in 
an  independent  CIE analysis using a  different concentrated  rabbit  IgG pool raised toward  a 
24-h extract of ragweed pollen. 
Radioimmunoassay of IgG and IgE Ab.  Radioimmunoassays  (RIA) of IgG and IgE Ab to Ra5 
were  performed  on  pretreatment  sera,  using  methodology  described  in  detail  elsewhere.  2 In 
brief, Ra5A was radiolabeled by the chloramine T  procedure, using 2 mCi of 125I per 40 pg of 
Ra5. After separation from unbound iodine by gel filtration and dialysis, the resultant solution 
was  adjusted  to  10  /~g  Ra5/ml  in  borate-buffered  physiological  saline  (BSS)  at  pH  8.3, 
containing 5% bovine serum albumin (BSA) as a stabilizer, millipore-filtered (Millipore Corp., 
Bedford, MA) to remove micro-precipitates, and stored at -70°C  until used. 
The  double-antibody  procedures  used  to  measure  IgG  and  IgE  Ab  levels  consisted  of 
incubating  100 pl of 125I-Ra5  (9 ng/ml in 5% BSA) with  100 #1  human  serum  (1/10  to  1/50 
dilution in BBS for the IgG assay or  1/2 dilution for the IgE assay)  for 4  h  at  23*C.  For the 
RIA of IgG Ab, goat anti-human  IgG (y-chain specific)  5 was added  in slight antibody excess, 
and the mixture was allowed to incubate for 18-20 h at 4*C. The resultant immunoprecipitates 
were washed  and  counted. 2 For the IgE Ab RIA,  100  ~1 of a  mixture of myeloma serum  PS 
(1/200)  plus  a  slight  excess  of  goat  anti-IgE  (E-chain-specific) 5  was  added  at  the  second 
incubation step (21).  The inclusion of the myeloma serum (kindly supplied by Dr. K. Ishizaka, 
The  Johns  Hopkins  University  School  of Medicine)  was  necessary  to  ensure  an  adequate 
amount  of precipitate  for subsequent  washing.  Further  procedures were performed  as  in the 
IgG RIA. Serum IgG and IgE Ab levels were computed by reference to a titration curve, using 
standard  serum  of known  high  IgG Ab content  (13)  after subtracting  values for blank  sera 
(containing no IgG or IgE Ab to Ra5). 
All analyses were performed  in triplicate in at  least two assays.  Further experiments were 
performed where the coefficient of variation was >10%  for the means of the first two assays. 
Sometimes as many as four or five assays were necessary to finalize anti-Ra5 Ab levels in diluted 
sera for the range of 0.3-1.0 ng/ml. 
Total  Serum IgE.  Total  serum  IgE  levels were  analyzed  by  the  direct  binding  assay  of 
Schellenberg  and  Adkinson  (22,  23).  This  technique  uses  anti-IgE-Sepharose  beads  as  an 
immunosorbent  for serum IgE. Bound IgE is subsequently detected using 125I-anti-IgE. 
Skin Test Procedures.  Intradermal skin test titration, using 0.05 ml of Ra5 at concentrations 
ranging from  10  -° to  1 /~g/ml, was performed as previously described  (6).  The sensitivity of a 
given individual was defined as the Ra5 concentration eliciting an 8- to  10-mm wheal  15-20 
min  after antigen  injection.  Puncture  skin  testing was  performed  according to Santilli et  al. 
(24), with modifications (15),  using dialyzed short ragweed pollen extract  (300/lg/ml),  Ra5A 
(10/~g/ml and  300/lg/ml), and phosphate-saline-human  serum albumin diluent control. The 
300/~g/ml concentration of Ra5 was used only when reaction at  10/~g/ml was <3-mm wheal 
Diam. Comparison of the two procedures ussng one-half-loga0 increments in antigen concentra- 
tion showed that  puncture  testing was ~ 1 million-fold less  sensitive than  intradermal  testing 
with respect to the relative antigen concentrations needed to induce end point wheals. 
HLA  Typing.  HLA-A,  B,  and  C  typing  was  performed  by  standard  microcytotoxicity 
technique  using  90  well-defined HLA typing sera  obtained  from  the NIH  serum  bank  and 
private sources.  In the case of the Westinghouse study,  a  constant  panel of HLA typing sera 
was maintained, with the exception of eight replacements that were well-standardized against 
the original sera.  A  somewhat  greater number  of replacements was permitted  for typing the 
local patients, depending on the availability of particular typing sera over a  3-yr period. 
HLA-D typing was  performed  using well-defined homozygous  typing cells obtained  from 
our Amish studies and other sources. HLA speeificities Dwl, 2, 3, 4, and 7/11 were each defined 
by two typing cells, and Dw5 and Dw6 were each defined by one typing cell. The cross-reacting 
4 This figure shows cathodically migrating antigens at pH 8.6. There are also ~40 anodically migrating 
antigens  in  short  ragweed  pollen  extract  (20). Independent  tests  showed  complete  absence  of other 
anodically and cathodically migrating antigens using up to 25/~g of Ra5A. 
5 Antisera used  as the second  antibody in the RIA were prepared by immunizing goats with the Fc 
fragments of human  IgG or IgE. The anti-IgG serum was  adsorbed  on an  IgG light-chain Sepharose 
column, where  necessary,  to  remove cross-reacting  antibody.  The  IgG fraction  of anti-IgE serum  was 
precipitated with ammonium sulfate  and was extensively  adsorbed on a  human  IgG-Sepharose  column 
several times to remove all traces of anti-IgG activity. MARSH ET AL.  1443 
specificities  Dw7 and  11  (Dw7/11)  were grouped together for analytical purposes. With the 
exception of some of the Westinghouse study group, all individuals were D typed at least twice. 
The  typing results were  analyzed by a  double-normalization procedure  using a  computer 
program reported at the 7th International Workshop (25). By this method, one may calculate 
the double-normalized values (DNV) for each stimulator-responder combination. In general, 
cells carrying the same allele as the typing cell  gave a  DNV below 35%, whereas those not 
sharing the allele gave a stimulation value of >60%. Ambiguous typing responses were usually 
resolved  by repeated D typing. 
HLA-DR  typing was  performed  according  to  our  modification  (26) of the  method  of 
vanRood et al. (27), using 70 sera of well-defined specificity with which we were able to identify 
speeifieities DR1 to DR8, DR10, MB(MT)1, MB2, MB3, and MT2. DR typing was performed 
on 37 clinic patients and 42 ragweed-sensitive Westinghouse subjects after most of the D typing 
had been completed. The main objective was to examine the concordance between DR and D 
typing data in relation to their association with response to Ra5. 
Data Analysis.  Patients' responses  to  Ra5A were evaluated primarily according to  their 
serum IgE or IgG Ab levels. Using diluted sera, we were unable to distinguish the epm values 
corresponding to Ab levels of 0.3 ng/ml as being significantly different from background cpm 
using the blank sera.  Because 1/10 and 1/2 serum dilutions were the highest concentrations 
used in the IgG and IgE assays, respectively, we could compute Ab levels in undiluted serum 
of >3 ng/ml in the case of IgG and >0.6 ng/ml in the case of IgE. Persons having lower than 
these detectable limits were considered to be negative for all nonparametric statistical analyses 
and were characterized as having levels of 3 ng/ml and 0.6 ng/ml of IgG and IgE Ab in the 
case of parametric tests. 
Allergic responses to Ra5A were also evaluated by skin testing the local clinic patients, 
initially using the puncture technique and, subsequently, the intradermal method in about 
one-third of the  patients.  Distinct wheal  reactions  (<3-mm  Diam  larger than  control)  on 
puncture testing with Ra5 at 10 #g/ml or 300/~g/ml were considered positive. Positive reactions 
seen only at  the higher concentration were confirmed by intradermal testing and found to 
correspond to a sensitivity end point of 10  -2 to 10  -3/Lg/ml. (At Ra5 concentrations higher than 
this level, even using ultra-pure Ra5A, reactions could be toward highly allergenic impurities 
at levels of 0.001 to 0.0001%.) 
In both the local and Westinghouse subjects, proportions of the different HLA specificities 
and the sex distribution Ra5+ vs. Ra5- groups (evaluated by IgE and IgG Ab determinations 
and skin testing) were compared by Fisher's exact test  (two-tailed). Relative risks were usually 
ad 
computed according to  the formula ~c' where a  is the number of Ra5+ subjects with the 
phenotype, b is the number of Ra5+ without the phenotype, c is the number of Ra5- subjects 
with the phenotype, and d is the number of Ra5- without the phenotype. In cases where b is 
2a +1  2d +1 
0, the formula of Haldane (28), ~  × ~--~,  was  used.  A t test  (two-tailed) was  used to 
analyze difference in age or log[total IgE] levels between the Ra5+ and Ra5-- groups. 
A more comphrehensive evaluation of the influence  of variables--such as HLA type, log[total 
IgE], age, sex, and previous immunotherapy on log[IgE Ab] or log[IgG Ab] level--was carried 
out by a series of stepwise  multiple regression  analyses using the Biomedical Data Programs 
package on a DEC-10 (Digital Equipment Corp., Maynard, MA) computer. For each individ- 
ual, HLA types were categorized, as 2, where the specificity was definitely present; 1, where the 
typing was equivocal (for certain D typings; see later); and 0, where the specificity was absent. 
Reported immunotherapy (allergen injections, including ragweed)  by the patient's clinician 
was categorized as 2, where injections had been given during the past 5 yr,  1 for injections 
given >5 yr ago, and 0 for no immunotherapy. 
Results 
Relationships between IgE Ab, IgG Ab, and Skin Test Response to Ra5.  Of 85 local clinic 
patients  for  whom  serum  samples  were  available,  29  (34%)  were  found  to  have 
detectable IgE Ab, and 34 (40%)  detectable IgG Ab to Ra5. Among 361 Westinghouse 1444  HLA-Dw2  AND  RESPONSE  TO  ALLERGEN  Ra5 
study  subjects,  101  (28%)  were  positive to crude  ragweed  extract  (300 /lg/ml)  by 
puncture skin test, and, of these, 9 (8.9%)  had detectable IgE Ab and  12 (11.9%)  had 
detectable IgG Ab to Ra5.  An additional two Westinghouse subjects, who were not 
positive to ragweed by puncture test, were found to have IgG Ab but no IgE Ab to 
Ra5. Among the  119 randomly sampled Westinghouse subjects, the prevalence rates 
for the Ra5 IgE Ab+ and Ra5 IgG Ab+ phenotypes were 1.7% and 3.4%, respectively. 
The difference in the proportion of Ra5+ persons among the clinic patients and the 
ragweed-allergic Westinghouse  subjects  reflects the  different selection criteria used 
(see Materials and Methods). 
Each of the frequency distributions of log[IgE Ab] and log[IgG Ab] levels among 
Ra5  responders  for the  clinic  and  the  Westinghouse  groups  was  not  significantly 
different  from  a  normal  distribution.  There were  no  significant  differences in  the 
proportions of males and females who were Ra5+  (categorized by either IgE or IgG 
Ab response) in either the clinic patients or the Westinghouse study group. The mean 
ages  of Ra5+  vs.  Ra5-  subgroups  were  also  not  significantly  different.  Among 
ragweed-positive  individuals  (either clinic  patients  or  Westinghouse  subjects),  the 
mean log[total IgE] levels between RaS+ vs. Ra5- subjects (by IgE or IgG Ab) were 
not significantly different. There was, however, a significant difference in the mean 
log [total  IgE]  for Ra5+  vs.  Ra5-  among the  total  group of Westinghouse study 
subjects, reflecting the very large proportion of nonallergic subjects with  low total 
serum IgE levels in the Ra5-  group. 
Only the clinic patients were extensively skin tested with Ra5. Among 18 subjects 
tested by the intradermal titration procedure, there was a weak correlation (r =  0.53, 
P  <  0.05)  between skin test sensitivity and log[IgE Ab]. All of the skin test-positive 
clinic patients had detectable IgE Ab to Ra5, except one individual (aged 63 yr) who 
was weakly skin test positive (intradermal sensitivity at 10  -2/~g Ra5/ml; 3-mm wheal 
on puncture testing at 300/.tg Ra5/ml). A low level of IgG Ab  (4 ng/ml) was found 
in this patient's serum. 
Fig. 2 shows that there is a good correlation (r =  0.84, P <  0.001) between log[IgG 
Ab] and log[IgE Ab] response to Ra5 in 34 local clinic and  13 Westinghouse subjects 
in  whom  IgG  Ab  responses  to  Ra5  were  detectable.  None  of these  subjects  were 
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F1o.  2.  Relationship between IgG Ab and IgE Ab levels to Ra5 in 47 subjects exhibiting positive 
IgG Ab responses. Subjects having IgG Ab but no detectable IgE Ab are contained within the box 
drawn in the bottom left  of the graph. One Westinghouse subject, currently on ragweed therapy, 
was excluded (see text), r =  0.842;  P <  0.00l. MARSH ET AL.  1445 
currently receiving immunotherapy with ragweed antigens; one Westinghouse Ra5+ 
subject,  who  was  receiving  high  dosage  ragweed  immunotherapy  and  had  an  ex- 
tremely high level of IgG Ab to Ra5, was omitted from this analysis. Only 37 of the 
47 IgG Ab+ subjects were IgE Ab+. The correlation between log[IgG Ab] and log[IgE 
Ab] was less strong (r ffi 0.657, P <  0.001) in these 37 study subjects. Among IgE Ab+ 
subjects, the geometric mean levels of IgG Ab and IgE Ab were  150  ng/ml and  21 
ng/ml,  respectively; among IgG Ab+  subjects,  the corresponding geometric means 
were 80 ng/ml and 9.8 ng/ml, respectively. The correlation between log[IgE Ab] and 
log[IgG Ab]  among Westinghouse  subjects  was  greater than  for the clinic  patients 
(r ~- 0.964  vs. 0.756),  probably because more of the clinic  patients  had  previously 
received  immunotherapy  with  ragweed  antigens.  The correlation  between  log[IgE 
Ab] and log[IgG Ab] was greater for 28 previously untreated vs. 19 previously treated 
subjects (r -- 0.903  vs. 0.775). 
Analysis of HLA  Associations  by Nonparametric Statistics.  The proportions  of all  the 
different  HLA types among Ra5+  vs Ra5-  individuals were compared using non- 
parametric statistics (Fisher's exact test, two-tailed). The only significant associations 
observed  in  both  groups  of subjects  were  with  HLA-B7  and  Dw2  (Table  I).  As 
indicated in the footnote to Table I, HLA-Aw 19 was significantly positively associated, 
and  HLA-Dw7/11  significantly negatively associated, with  response to  Ra5  in  the 
clinic patients. Considering the number of HLA specificities studied, these associations 
are  not  very  strong.  Furthermore,  they  were  not  confirmed  by  analysis  of  the 
Westinghouse group. In fact, there was a nonsignificant positive association between 
Dw7/11 and response to Ra5 in the Westinghouse subjects (see also multiple regression 
analyses where the association was significant in the Westinghouse subjects). 
The striking findings were the particularly strong associations between Dw2  and 
both- IgE Ab and IgG Ab responses to Ra5 in the two study groups. This was especially 
noteworthy in the case of IgE Ab, where all nine of the Westinghouse Ra5+ subjects 
and  27/29  of the Ra5+ clinic patients had Dw2.  (For all ragweed-positive subjects, 
P  <  0.0001,  relative  risk  is  65.)  The  skin  test-positive clinic  patient  who  had  no 
detectable IgE Ab was also found to have Dw2. We retyped the two Ra5+,  Dw2- 
clinic patients twice, and the absence of Dw2 was confirmed.  6 
In view of a preliminary finding (30) showing that the HLA-A3, B7, Dw2 phenotype 
is significantly associated with the general expression of allergy in the Westinghouse 
group,  we  were  interested  to  ascertain  whether  the  associations  between  various 
combinations of A3, B7, and Dw2 might be stronger than with Dw2 itself. This was 
found not to be the case. As shown in Fig.  3, the relative risks of having IgE Ab to 
Ra5  are  much  greater  among  individuals  with  Dw2  than  for  any  of  the  other 
phenotypic  combinations  of  A3,  B7,  and  Dw2  in  clinic  patients,  Westinghouse 
ragweed-positive subjects, and the total Westinghouse group. 7 Similar findings were 
noted in analyzing the IgG Ab data (not shown). These results clearly show that the 
primary HLA association with response to Ra5 is with Dw2 and not with combinations 
of HLA antigens. 
In a preliminary report of these data (29), we had identified three Ra5+ clinic patients as being Dw2-. 
One of these three individuals, who had left the area, was recently located and was retyped twice using 
three Dw2 homozygous typing cells in each experiment. Both experiments showed unequivically that he 
was Dw2+ by all three typing cells. 
7  The Haldane (28) formula was used to compute data for Dw2 in the Westinghouse groups where no 
Ra5+ subject was Dw2-. 1446  HLA-Dw2  AND RESPONSE TO  ALLERGEN  Ra5 
TABLE  I 
Associations  between HLA and Immune  Responses to Ra5 in Clinic and  Westinghouse  Study  Patients * 
Percent with  Percent with 
Number of subjects  B 7  P vat-  Dw2 
Study group  P values 
ues 
Ra5+  Ra5-  Ra5+  Ra5-  Ra5+  Ra5- 
1.  Local clinic patients; IgE Ab~  29  56  52  29  0.056  93  18  <0.0001 
2.  Local clinic patients; IgG Ab  34  51  50  27  0.041  85  16  <0.0001 
3.  Local  clinic  patients;  skin  30  56  53  27  0.019  93  16  <0.0001 
test~ 
4.  Ragweed-positive Westing-  9  92 (83)§  56  25  0.11  100  24  <0.0001 
house;  IgE Ab 
5.  Ragweed-positive Westing-  12  89 (80)§  50  25  0.087  83  24  0.0001 
house; IgG Ab 
6.  All  Westinghouse  subjects;  9  352(326)§  56  22  0.033  100  2l  <0.0001 
IgE Ab 
7.  All  Westinghouse  subjects;  14  347 (321)§  50  22  0.022  79  21  <0.0001 
IgG Ab 
Combined groups  1 and 4;  IgE  38  148 (139)§  53  26  0.004  951[  22  <0.0001 
Ab 
Combined groups  2 and 5; IgG  46  140 (131)§  50  26  0.004  85  21  <0.0001 
Ab 
* Significant positive associations  (0.05 >  P >  0.01) between immune responsiveness to Ra5 (detected  by 
IgE Ab,  IgG Ab and skin  test)  were seen  in the local clinic patients  for HLA-AwI9 (combined A29, 
Aw30, Aw31, Aw32, and Aw33), and significant negative associations  (0.05 >  P z- 0.01) were seen with 
HLA-Dw7/11 (Dw7 and/or Dwl 1). These associations were not confirmed in the Westinghouse  subjects 
(see text). 
:~.Pretreatment  serum was not available on one Ra5- patient. Also, one weakly skin test-positive  subject 
had no detectable IgE Ab; hence the numbers in the Ra5+ and Ra5- categories  are not identical. 
§ Westinghouse  subjects having equivocal typings  for HLA-Dw2 (9 Ra5- subjects in the ragweed-positive 
and  26 in the total Westinghouse  study group)  were included in  the B7 but  excluded from the Dw2 
analyses  (see text). The reduced numbers given in parentheses  reflect the subjects  for whom definitively 
positive or negative typings for Dw2 were obtained. 
I[ The D/DR typings on the two Dw2- individuals were: Dwl/DR1, Dw?/DR?, MB(MT) 1;  Dw?/DR4, 
Dw?/DR8, MB?, MT2. 
Multiple  Regression  Analyses.  To  obtain  more  discriminating  analyses  of the  data 
sets, relating HLA etc. to the magnitude of the IgE Ab or IgG Ab response to Ra5, we 
carried out a  series of stepwise multiple regression analyses.  The different HLA  types, 
age,  sex,  previous  ragweed  immunotherapy,  and  log[total  serum  IgE]  were  the 
independent  variables and  log[IgE Ab] or log[IgG Ab], the dependent  variables.  The 
following groups  were analyzed:  clinic patients,  ragweed-positive Westinghouse  sub- 
jects, and  all Westinghouse  subjects.  HLA-Dw2  showed  by  far the strongest  associa- 
tions with log[IgE Ab]  and  log [IgG Ah]  to Ra5  in both study  groups,  with  P  values 
of  10 -6 to  10  -14.  In  addition,  log[IgG Ab]  was  significantly  associated  with  previous 
immunotherapy.  Among  one or the other ragweed-positive groups,  less striking  (but 
significant)  associations  were  observed  with  A2,  A3,  B5,  B14,  Bw35,  Cw3,  and 
Dw7/11,  of which  A2  and  B14  were negatively  associated  with  response  to  Ra5.  In 
the  total  Westinghouse  group,  log[total  IgE]  was  also  significantly  associated  with 
response to Ra5 because of the large proportion  of nonallergics in the  Ra5-  group. 
We  wished  to  compare,  critically,  the  relative  influence  of each  of the  variables 
significantly associated with response to Ra5  in at least one of the analyses of IgE Ab MARSH  ET  AL.  1447 
62  ~i 
IO 
3 
r 
59 3 
~  30 
Clinic Patients 
(N=85) 
Westinghouse Ragweed Pos. 
(N=IOI) 
All Westinghouse 
(N=361) 
AB  B7 DW2  B,7 7,2 3,2  3,7,2 
Fxo.  3.  Comparison of relative  risks  for IgE Ab response to Ra5  in persons having phenotypes 
HLA-A3, B7, Dw2, or various combinations thereof. Significant associations are indicated as follows: 
* 0.05 ~  P >  0.01 ; t  0.01  ~  P :> 0.001;  ~: 0.001  ~  P >  0.0001;  ¶ P <  0.0001. 
TABLE  II 
Multiple Regression Analyses Examining Relationships between Log[IgE Ab] and Log[IgG Ab] 
Responses to Ra5 and the Independent Variables Found to Be Significant in Previous Stepwise Multiple 
Regressions 
Clinic patients (N =  85)*  Westinghouse ragweed (N =  97):1: 
Independent  log[IgE Ab]  log[IgG Ab]  log[IgE Ab]  log[IgG Ab] 
variable 
b§  pll  b  PIt  b  e  b  p 
A2  -0.138  0.047  -0.125  0.074  0.063 
A3  -0.029  -0.038  0.223  0.020  0.204  0.028 
B5  0.246  0.001  0.271  3.3 X  10  -4  -0.022  --0.020 
B14  -0.233  0.001  -0.171  0.017  0.126  0.109 
B27  -0.029  -0.030  0.215  0.018  0.215  0.015 
Bw35  0.201  0.005  0.106  0.082  0.042 
Cw3  0.197  0.007  0.107  -0.063  -0.058 
Dw2  0.691  1.8 x  10 -t4  0.698  1.6 x  10  -t4  0.430  7.9 x  10  -6  0.446  2.1  x  10  -6 
Dw7/11  -0.075  -0.081  0.276  0.003  0.295  0.001 
Previous Rx  0.051  0.155  0.034  0.114  0.192  0.033 
* Pretreatment serum was not available on one clinic patient. 
D-locus typing data were not available on four subjects. 
§ Standardized regression coefficient. 
I1 Two-tailed tests.  Only values of P _< 0.05 are cited. 
or IgG Ab responses in ragweed-positive individuals. Therefore, in a series of multiple 
regression analyses, we investigated the association between each of these variables 
and log[IgE Ab] or log[IgG Ab]  in clinic patients and in Westinghouse employees. 
The results (Table II) show that only Dw2 is significantly associated with response to 1448  HLA-Dw2  AND  RESPONSE  TO  ALLERGEN  Ra5 
Ra5  in  all  of the  categories  studied  (P values  of  10  -2  to  10-14). In  addition,  the 
influence of previous immunotherapy with ragweed is evident for the analyses of IgG 
Ab response both for the clinic and Westinghouse subjects. For all other independent 
variables, significant  associations  (P <  0.05)  were  found  either  in  the  clinic  or the 
Westinghouse group, but not simultaneously in both groups.  No significant associa- 
tions were found between response to Ra5 and the presence of HLA-B7 in any of the 
multiple regression analyses. This is because of the association ("arising from" linkage 
disequilibrium)  between HLA-B7 and Dw2, which  precludes finding an association 
between  response  to  Ra5  and  B7  in  the  presence of the  overwhelming association 
between Ra5 response and Dw2. 
DR-D Relationships.  Finally, we investigated whether DR typing data could clarify 
the HLA associations further.  We DR typed 79 subjects  (37  clinic and 42 Westing- 
house),  of whom  13  clinic  and  7 Westinghouse  subjects  had  detectable  IgE Ab  to 
Ra5. The people who were DR typed were not random samples of the two groups; 
they were chosen to include  as many Ra5+ subjects as possible, especially the  two 
Ra5+,  Dw2-  subjects.  Analysis of the  data  by Fisher's exact  test  showed  that  the 
primary DR association with  IgE Ab response to Ra5  was with  DR2  (P <  0.000l; 
relative risk,  19). The association of IgE Ab response to Ra5 with Dw2 in these same 
79  subjects  was  more striking  (P <  0.0001;  relative  risk,  29).  DR5  was  negatively 
associated with IgE Ab to Ra5 (P <  0.02); no Ra5+ but five Ra5-  subjects had DR5. 
Similar results were obtained in analyzing IgG Ab data. 
The IgE Ab data showed complete concordance between typings for Dw2 and DR2 
for all 20 Ra5+ subjects studied.  We found that the two exceptional  Ra5+,  Dw2- 
clinic  patients  were  also  DR2-.  Among  the  59  Ra5-  subjects,  DR2  was  present 
in  32% and Dw2  in  24%  of the cases.  Four Ra5-  clinic patients and one Westing- 
house subject were DR2+,  Dw2-;  none was DR2-,  Dw2+.  There were no unusual 
MB/MT-DR relationships for subjects having either the Ra5+, DR2-, Dw2- or the 
Ra5-, DR2+, Dw2- phenotypes. 
Discussion 
In  two  different  groups  of Caucasian  subjects,  we  demonstrated  significant,  ex- 
tremely  strong  associations  between  human  immune  response  to  short  ragweed 
allergen  Ra5  and  possession  of HLA-Dw2.  In  the  case  of IgE  Ab  response,  the 
association  is  particularly  striking;  overall,  95%  of 38  Ra5+  vs.  22%  of  139  Ra5- 
ragweed-allergic subjects possessed Dw2 (P <  0.0001;  relative risk, 65). These conclu- 
sions were confirmed by the use of multiple regression analyses, where Dw2 was found 
to be strongly correlated  with  the  magnitude  of the  log[IgE Ab]  and  log[IgG Ab] 
levels. Associations were significant with P values of ~ 10  -a4 in the clinic patients and 
10  -~ to  10  -6 in the Westinghouse ragweed-allergic subjects (Table II). 
The Dw2-Ra5  association  is  by far the strongest  HLA association  that  has been 
observed with  a  defined  immune response in  humans.  The association is of similar 
magnitude  to  that  found  between  B27  and  ankylosing spondylitis  (31),  a  disease 
where there is no clear-cut  association with  a  specific immune response.  Allergy to 
Ra5  requires  production  of anti-Ra5  IgE Ab;  furthermore,  there  is  a  concordant 
production of specific IgG Ab (in sevenfold higher concentration) in IgE Ab+ subjects. 
Some additional subjects make low levels ofIgG Ab but no detectable IgE Ab to Ra5. 
As  noted  with  response  to  other  inhaled  allergens  (21,  32,  33),  there  is  a  good MARSH  ET  AL.  1449 
correlation between log[IgG Ab] and log[IgE Ab] to Ra5 in responder subjects not 
currently receiving allergen immunotherapy (Fig.  1). The somewhat weaker associa- 
tion between Dw2 and IgG Ab response in the nonparametric (but not the multiple 
regression) analyses might result from the influence of previous immunotherapy with 
ragweed antigens in many of the study subjects. The significant influence of previous 
immunotherapy on IgG Ab response is clearly evident from the multiple regression 
analyses (Table II). 
The crucial elements in the success of these studies were (a) the use of an ultra-pure 
(_>99.9% pure) sample of a defined polypeptide antigen of relatively simple structure 
(45 amino acids)  (5), and (b) the development of highly sensitive RIA procedures to 
measure serum IgE Ab and IgG Ab responses. It should be emphasized that, in the 
highly polymorphic human population, studies using partially purified (ca. 95% pure) 
or highly complex protein antigens might not yield informative data (7). 
In previous studies  (6,  7), we observed a  significant association between allergic 
skin test response to Ra5 and HLA-B7. It now appears that the primary association 
is  with  Dw2  and  that  the  B7  association  results  from  the  linkage disequilibrium 
between B7 and Dw2. In view of several reports (26, 31) suggesting stronger associa- 
tions between various autoimmune diseases and DR (as opposed to D) specificities, it 
is interesting to find that  Dw2, rather than DR2, is more strongly associated with 
response to Ra5. Among subjects who were DR typed, no discordance was observed 
in 20 Ra5+ subjects between DR2 and Dw2;  18 of 20 had the DR2, Dw2 phenotype, 
and the remaining two individuals were negative for both specificities. On the other 
hand, among 59 Ra5- individuals, 5 of 18 (28%) of the subset who typed DR2+ were 
Dw2-.  Other  data  (34) suggest  that,  in  Caucasian  populations,  -24%  of DR2+ 
subjects do not have an associated Dw2 specificity. 
The finding of a large number of Ra5-, Dw2+ subjects raised the obvious question 
of whether  there  might  be  other  genetic  factors  (as  well  as  the  obvious  need  for 
environmental exposure)  determining response to Ra5.  Also, could such  factors be 
circumvented by artificial  immunization with  much  higher  dosages of Ra5  than 
encountered as a result of natural inhalation of pollen grains? The widespread use of 
immunotherapy with ragweed antigens for the treatment of ragweed allergy provides 
a  ready-made  experiment  to  test  the  latter  hypothesis.  The  results  of such  an 
investigation, together with mechanistic interpretations of the Ra5-Dw2 association, 
are presented in the succeeding paper. 
Summary 
Ultra-pure short ragweed pollen allergen Ra5 (5,000 tool wt) was used to investigate 
the relationship between human  leukocyte antigen  (HLA)  type and  IgE and  IgG 
antibody (Ab)  responses to Ra5  in two groups of Caucasian subjects, totaling 447 
people. Using highly sensitive radioimmunoassay procedures to measure serum IgE 
and IgG Ab, qualitative responses to Ra5 in both groups were found to be strongly 
associated with HLA-Dw2 (P <  0.0001).  For example, 95% of 38 people with IgE Ab 
vs.  22% of 139  ragweed-allergic persons having no detectable IgE Ab  to Ra5 were 
Dw2+.  Quantitative log  [IgE  Ab]  and log[IgG Ab]  responses to  Ra5  were highly 
correlated with Dw2 (P ffi 10  -5 to l0  -14) in four separate multiple regression analyses, 
examining the relationship between HLA type (and other variables) and Ab levels in 
the two study groups.  Further studies showed that  the primary association of Ra5 1450  HLA-Dw2  AND  RESPONSE  TO  ALLERGEN  Ra5 
response was with Dw2 rather than DR2 and that  various combinations of A3,  B7, 
and Dw2 were less strongly associated than Dw2 alone. 
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